Evaluation of monolithic osmotic tablet system for nifedipine delivery in vitro and in vivo

Drug Development and Industrial Pharmacy

Volumn 29, Issue 7, 2003, Pages 813-819

  Liu, Xing ^a   Chen, Dawei ^a   Zhang, Ruhua ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

In vitro; In vivo; Monolithic osmotic tablet system; Nifedipine

Indexed keywords

MACROGOL; NIFEDIPINE;

ADULT; ARTICLE; BINDING KINETICS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISPERSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG RELEASE; DRUG SCREENING; EVALUATION; HUMAN; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MATERIAL COATING; MONOLITHIC OSMOTIC TABLET SYSTEM; OSMOSIS; PH MEASUREMENT; POROSITY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TABLET FORMULATION; ZERO ORDER KINETICS;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; HUMAN EXPERIMENTATION; HUMANS; MALE; NIFEDIPINE; OSMOSIS; TABLETS; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 0041345823     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120021781     Document Type: Article

References (25)

1. Santus, G.; Baker, R.W. Osmotic drug delivery: a review of the patent literature. J. Contr. Rel. 1995, 35, 1-21.
2. Ross, S.; Nelson, J.F. A continuous long-term injector. J. Exp. Biol. 1995, 33, 415-420.
3. Theeuwes, F.; Higuchi, T. Osmotic Dispensing Device for Releasing Beneficial Agent. US Patent 3,845,770, 1972.
4. Higuchi, T.; Leeper, H.M. Osmotic Dispenser with Means for Dispensing Active Agent Responsive to Osmotic Gradient. US Patent 3,995,631, 1976.
5. Baker, R.W. Controlled Release Delivery System by an Osmotic Bursting Mechanism. US Patent 3,952,741, 1976.
6. Theeuwes, F. Oral dosage forms design status and goals of oral osmotic system technology. Pharm. Int. 1984, 5, 293-296.
7. Amidon, G.L.; Higuchi, T.; Dressman, J.B. Lipid Osmotic Pump. US Patent 4,685,918, 1987.
8. Zentner, G.M.; Rork, G.S.; Himmelstein, K.J. The controlled porosity osmotic pump. J. Contr. Rel. 1985, 1, 269-282.
9. Haslam, J.L.; Merfeld, A.E.; Rork, G.S. Surface wetting effects in the lipid osmotic pump. Int. J. Pharm. 1989, 56, 227-233.
10. Theeuwes, F. Elementary osmotic pump. J. Pharm. Sci. 1975, 64, 1987-1991.
11. Higuchi, T. Osmotic Dispenser with Collapsible Supply Container. US Patent 3,760,805, 1973.
12. Swanson, D.R.; Barclay, B.L.; Wong, P.S.L.; Theeuwes, F. Nifedipine gastrointestinal therapeutic system. Am. J. Med. (Suppl. 68) 1987, 83, 3-9.
13. Cortese, R.; Barclay, B.; Theeuwes, F. Simultaneous Delivery of Two Drugs from Unit Delivery Device. US Patent 4,449,983, 1984.
14. Chen, C.M.; Lee, D.T.; Xie, J. Controlled Release Formulation for Water Insoluble Drug in Which a Passageway is Formed In Situ. US Patent 5,736,159, 1998.
15. Chen, C.M.; Chou, J.C.H. Once Daily Pharmaceutical Tablet Having a Unitary Core. US Patent 5,837,39, 1998.
16. Horvath, V.; Hrabeczy-Pall, A; Niegreisz, Z.; Kocsi, E.; Horvai, G. Sensitive high-performance liquid chromatographic determination of nifedipine in dog plasma using an automated sample preparation system with laboratory robot. J. Chromatogr. B 1996, 686, 2211-2219.
17. Gibaldi, M.; Perrier, P. Pharmacokinetics; Marcel Dekker, Inc.: New York, 1982.
18. Ali, S.L. Nifedipine. In Analytical Profiles of Drug Substances; Florey, K., Ed.; Academic Press: New York, 1989; Vol. 18, 221-288.
19. Grundy, J.S.; Foster, R.T. The nifedipine gastrointestinal therapeutic system (GITS): evaluation of pharmaceutical, pharmacokinetic and pharmacological properities. Clin. Pharmacokinet. 1996, 30, 28-51.
20. Takahashi, M.; Mochizuki, M.; Itoh, T.; Ohta, M. Studies on dissolution test for soft gelatin capsule containing water-soluble vehicles by the rotating dialysis cell method. Chem. Pharm. Bull. 1994, 42, 333-336.
21. Chen, D.W.; Liu, X.; Fu, W.Y. Studies on preparation and dissolution of the solid dispersions of nifedipine-polyvinylpyrroli-done. Chinese Pharmaceutical J. 2000, 35, 598-600.
22. Okimoto, K.; Miyake, M.; Ohnishi, N.; Rajewske, R.A.; Stella, V.J.; Irie, T.; Uekama, K. Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE) β-cyclodextrin. Pharm. Res. 1998, 15, 1562-1568.
23. Okimoto, K.; Rajewski, R.A.; Stella, V.J. Release of testosterone from an osomtic pump tablet utilizing (SEB) β-cyclodextrin as both a solubilizing and an osmotic pump agent. J. Contr. Rel. 1999, 58, 29-38.
24. Theeuwes, F.; Higuchi, T. Osmotic Dispensing Device with Maximum and Minimum Size for the Passageway. US Patent 3,916,899, 1975.
25. Janicki, S.; Cichon, R.; Jedras, Z.; Sawichi, W. Gastrointestinal therapeutic system delivering of a water insoluble drug: isosorbide dinitrate (ISDN). Pharmazie. 1987, 42, 95-96.